Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03390998 · ClinicalTrials.gov registry record

Angiographic and Psychosocial Evaluation of Peripartum vs. Non: SCAD

A clinical trial of Spontaneous Coronary Artery Dissection, sponsored by Katharine Sears Edwards.

Completed
Registry status
241
Enrollment target
1
Study location

NCT03390998: Completed study of Spontaneous Coronary Artery Dissection, sponsored by Katharine Sears Edwards.

NCT03390998 is a study of Spontaneous Coronary Artery Dissection that has completed, run by Katharine Sears Edwards. The registered enrollment target is 241 participants, below the 840-participant average among 5 other Spontaneous Coronary Artery Dissection trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03390998, a study of Spontaneous Coronary Artery Dissection, has completed, sponsored by Katharine Sears Edwards.

COMPLETED
Registry status
241 participants
Enrollment target
1
Study location

Study Summary

This multi-site international clinical research project is a collaboration between investigators from multiple institutions in the USA, Canada, and Europe. Approximately 7 to 11 sites will participate and provide data for analysis. Clinical operations (for data collection and analysis) across sites will be managed by Stanford. The study purpose is to determine differences in clinical and imaging presentation, in-hospital management and prognosis in peripartum and non-peripartum SCAD patients.

Primary Outcome

The time from the first SCAD event until the first occurrence of (1) myocardial infarction, (2) re-vascularization, (3) stroke, or (4) death due to cardiovascular cause.

Study Locations (1)

California

  • Stanford University Medical Center - Palo Alto

Trial Details

FieldValue
Enrollment Target 241 participants
Start Date 2017-11-28
Est. Completion 2019-05-31
Katharine Sears Edwards

1 total trials

What the finished NCT03390998 record still lists

NCT03390998 is an observational study that tracks outcomes without assigning an intervention. The registered 241 participants enrollment target is mid-sized for trials with a published cap, below the 840-participant average among 5 other Spontaneous Coronary Artery Dissection trials with a reported enrollment target (71% lower).

The record links to 1 condition, with Spontaneous Coronary Artery Dissection appearing as the primary indexed condition, and to 0 interventions.

NCT03390998 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03390998 about?

NCT03390998 is a clinical study titled "Angiographic and Psychosocial Evaluation of Peripartum vs. Non: SCAD". This multi-site international clinical research project is a collaboration between investigators from multiple institutions in the USA, Canada, and Europe. Approximately 7 to 11 sites will participate and provide data for analysis. Clinical operations (for data collection and analysis) across sites ...

What is the current status of trial NCT03390998?

This trial is currently completed. The enrollment target is 241 participants. The study started on 2017-11-28. Estimated completion is 2019-05-31.

What conditions does trial NCT03390998 study?

This clinical trial studies the following conditions: Spontaneous Coronary Artery Dissection.

Who is sponsoring clinical trial NCT03390998?

This trial is sponsored by Katharine Sears Edwards, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03390998 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spontaneous Coronary Artery Dissection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01189786 · 241 participants · NA

    Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection

  • NCT05050383 · 241 participants · NA

    DISE: Phenotyping Obstruction Patterns

  • NCT05683418 · 241 participants · Phase 1

    A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors

  • NCT07213791 · 241 participants · Phase 1

    A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03390998, the US trial registry maintained by the National Library of Medicine. NCT03390998 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.